Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia
- 1 March 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 122 (2) , 213-219
- https://doi.org/10.1016/0014-2999(86)90105-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion‐induced arrhythmias in anaesthetized greyhoundsBritish Journal of Pharmacology, 1985
- Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemiaBasic Research in Cardiology, 1985
- Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarctionAmerican Heart Journal, 1985
- Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoidsCanadian Journal of Physiology and Pharmacology, 1984
- Pathophysiological mechanisms of sudden death induced by platelet activating factorBritish Journal of Pharmacology, 1984
- Protection of Ischemic Cat Myocardium By CGS-13080, a Selective Potent Thromboxane A2 Synthesis InhibitorJournal of Cardiovascular Pharmacology, 1983
- Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden deathThrombosis Research, 1981
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.Circulation, 1980
- Long-Term Preservation of Ischemic Myocardium after Experimental Coronary Artery OcclusionJournal of Clinical Investigation, 1978